Spotted in the FTMerck has signed a landmark voluntary licensing deal with the UN-backed Medicines Patent Pool to expand low-cost access to its Covid-19 antiviral pill throughout the developing world.
It is one of the first royalty-free licensing agreements struck by a pharmaceutical company for a key Covid-19 medical technology and should boost generic manufacturing of Merck’s drug molnupiravir if it is authorised by regulators, according to experts.
Merck signs royalty-free licensing deal to expand global access to its Covid-19 pill - https://on.ft.com/3bebLhc via @FT